Gilead Sciences, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Foster City, CA
GILD chart
What traders are saying about $GILD
Latest postsGilead Sciences, Inc. news
- Jefferies raises target for Gilead Sciences stock from USD 184.00 to USD 185.00
ad-hoc-news.de ·
- Gilead (GILD) Stock Could Be 50% Undervalued On New Oncology Trial News
Yahoo Finance ·
- Gilead to Report Q3 Earnings: How Should You Play the Stock Now?
Yahoo Finance ·
- Vertex Gears Up to Report Q3 Earnings: Is a Beat in the Cards?
Yahoo Finance ·
- What's in Store for These 5 Drug/Biotech Stocks in Q3 Earnings?
Yahoo Finance ·
- Canadians Living with Primary Biliary Cholangitis (PBC) One Step Closer to New Treatment Option as Gilead Reaches Milestone National Agreement for LYVDELZI® (seladelpar)
Yahoo Finance ·
- BofA lifts Gilead target to USD 172 as Gilead Sciences stock trades EUR 141.85
ad-hoc-news.de ·
- ETFs Are Net Sellers of Gilead Sciences (GILD) on Oct. 23
Yahoo Finance ·
- Gilead Sciences (GILD) Could Be 24% Above Fair Value As Settlement News Lands
Simply Wall Street ·
- What Would A Biktarvy Slowdown Do To Gilead Stock?
trefis.com ·
- Gilead Sciences Inc. stock outperforms competitors on strong trading day
MarketWatch ·
- Gilead Sciences Q3 2026 Earnings Preview — October 29, Street Expects $2.21 EPS
AlphaStreet ·
Gilead Sciences, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $29.44B | $28.75B | $27.12B | $27.28B |
| Net income | $8.51B | $480.0M | $5.67B | $4.59B |
| Diluted EPS | $6.78 | $0.38 | $4.50 | $3.64 |
| Total assets (year end) | $59.02B | $58.99B | $62.13B | $63.17B |
| Cash and equivalents (year end) | – | – | – | $5.41B |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Gilead Sciences, Inc.
- Ticker
- GILD (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Foster City, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 882095
- Former names
- GILEAD SCIENCES INC
Frequently asked questions
What exchange is Gilead Sciences, Inc. listed on?
Gilead Sciences, Inc. trades on the Nasdaq under the ticker symbol GILD.
What industry is Gilead Sciences, Inc. in?
Gilead Sciences, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Gilead Sciences, Inc. headquartered?
Gilead Sciences, Inc.'s business address on file with the SEC is in Foster City, CA.
When does Gilead Sciences, Inc.'s fiscal year end?
Gilead Sciences, Inc.'s fiscal year ends on December 31.
How much revenue did Gilead Sciences, Inc. report?
Gilead Sciences, Inc. reported $29.44B in revenue for calendar year 2025, according to its SEC filings.